Literature DB >> 10759718

IgA myeloma of donor origin arising 7 years after allogeneic renal transplant.

M Grey1, N Townsend, D Lappin, I Roberts, R Stanford, M Sheldon, D Tate, C Short, G Lucas.   

Abstract

We report the case of a 38-year-old man who developed IgA myeloma of donor origin 7 years after allogeneic renal transplant. The diagnosis of multiple myeloma was unequivocal and based on positive results from serum electrophoresis, skeletal survey and bone marrow investigations. The donor origin of the myeloma cells was confirmed by DNA fingerprinting. We believe this is the first reported case of disseminated multiple myeloma of donor origin developing after allogeneic renal transplant and, as such, gives some insight into the natural history and biology of the disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759718     DOI: 10.1046/j.1365-2141.2000.01913.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Authors:  Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

2.  Plasma cell myeloma in a renal transplant recipient: A case report and review of literature.

Authors:  S Sharma; C Rana; P B Vinod; A Gupta
Journal:  Indian J Nephrol       Date:  2011-10

Review 3.  Plasma cell neoplasia after kidney transplantation: French cohort series and review of the literature.

Authors:  Raphaël Kormann; Hélène François; Thibault Moles; Jacques Dantal; Nassim Kamar; Karine Moreau; Thomas Bachelet; Anne-Elisabeth Heng; Antoine Garstka; Charlotte Colosio; Didier Ducloux; Johnny Sayegh; Benjamin Savenkoff; Denis Viglietti; Rebecca Sberro; Eric Rondeau; Julie Peltier
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

4.  Donor cell myeloid sarcoma.

Authors:  Mark A Walshauser; Aileen Go; Payal Sojitra; Girish Venkataraman; Patrick Stiff
Journal:  Case Rep Hematol       Date:  2014-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.